NASDAQ:NPCE

Neuropace Stock Insider Trading

Healthcare > Medical - Devices

Buy NPCE

*Your capital is at risk

$12.89

-0.86 (-6.25%)

At Close: Jul 31, 2026

NeuroPace Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 32.09. In total, the insiders bought 576.88K and sold 58.29K NPCE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	32.09
● Buy	576.88K shares
● Sell	58.29K shares
77% Buy Activity Moderate Negative Correlation
Buy Signal Medium Confidence May 15, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 32.09. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (77% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 19, 2025 Buy	Common Stock A-Award	Lacob Joseph Director	Director	1 131 Value: $11.2K
Sep 19, 2025 Buy	Common Stock A-Award	Geiger Uri Director	Director	1 194 Value: $11.9K
Sep 03, 2025 Sell	Common Stock F-InKind	Morrell Martha Chief Medical Officer	Officer	1 337 Value: $12.5K
Sep 03, 2025 Sell	Common Stock F-InKind	Morrell Martha Chief Medical Officer	Officer	1 337 Value: $12.5K
Aug 27, 2025 Sell	Common Stock F-InKind	Becker Joel Chief Executive Officer	CEO / President	1 126 Value: $10K
Aug 27, 2025 Sell	Common Stock F-InKind	Morrell Martha Chief Medical Officer	Officer	357 Value: $3K
Aug 27, 2025 Sell	Common Stock F-InKind	Morrell Martha Chief Medical Officer	Officer	357 Value: $3K
Aug 27, 2025 Sell	Common Stock F-InKind	Becker Joel Chief Executive Officer	CEO / President	1 126 Value: $10K
Aug 20, 2025 Sell	Common Stock F-InKind	Morrell Martha Chief Medical Officer	Officer	3 052 Value: $26.4K
Aug 20, 2025 Sell	Common Stock F-InKind	Morrell Martha Chief Medical Officer	Officer	3 052 Value: $26.4K
Jun 21, 2025 Buy	Common Stock A-Award	Geiger Uri Director	Director	1 140 Value: $11.9K
Jun 21, 2025 Buy	Common Stock A-Award	Kumar Rakhi Director	Director	1 440 Value: $15.0K
Jun 21, 2025 Buy	Common Stock A-Award	Lacob Joseph Director	Director	1 080 Value: $11.2K
Jun 21, 2025 Buy	Common Stock A-Award	Fischer Frank M Director	Director	2 281 Value: $23.7K
Jun 21, 2025 Buy	Common Stock A-Award	Geiger Uri Director	Director	1 140 Value: $11.9K
Jun 20, 2025 Buy	Stock Option (Right to Buy) A-Award	Williams Patrick F. Chief Financial Officer	C-Suite Officer	87 950 Value: $915.6K
Jun 20, 2025 Buy	Common Stock A-Award	Williams Patrick F. Chief Financial Officer	C-Suite Officer	51 850 Value: $539.8K
Jun 20, 2025 Buy	Common Stock J-Other	Williams Patrick F. Insider	Other	0 Value: $0
Jun 20, 2025 Buy	Common Stock J-Other	Williams Patrick F. Insider	Other	0 Value: $0
Jun 20, 2025 Buy	Common Stock A-Award	Williams Patrick F. Chief Financial Officer	C-Suite Officer	51 850 Value: $539.8K
Mar 21, 2025 Buy	Common Stock A-Award	Geiger Uri Director	Director	987 Value: $11.9K
Mar 21, 2025 Buy	Common Stock A-Award	Kumar Rakhi Director	Director	1 247 Value: $15.0K
Mar 21, 2025 Buy	Common Stock A-Award	Fischer Frank M Director	Director	1 975 Value: $23.7K
Mar 21, 2025 Buy	Common Stock A-Award	Geiger Uri Director	Director	987 Value: $11.9K
Dec 21, 2024 Buy	Common Stock A-Award	Geiger Uri Director	Director	1 029 Value: $11.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NEUROPACE, INC.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilitie...

Read Full Profile Here